Company / Gross Margin
Idexx Laboratories Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
61.8%
FY2025
5-year range
58.8% / 61.8%
FY2021-FY2025
Trend
+1.2%
vs FY2024
Sector context
#39 of 91
Health Care
What the data says
At 61.8%, Idexx Laboratories's gross margin ranks #39 of 91 in the Health Care sector. Gross Margin has increased for 9 consecutive years, from 54.9% in FY2016 to 61.8% in FY2025.
Based on SEC 10-K filings.
61.8% in FY2025 with a 5-year CAGR of +3.8%.
Improved from 59.8% to 61.8% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- +2.3pp
- 5-Year Change
- +3.8pp
- 10-Year Change
- -
Sector benchmark
#39 of 91 in Health CareTop 43% of 91This company 61.8% Sector average 53.8%
▼
+14.9% above sector average
Key checks
Key Insights
- Idexx Laboratories's gross margin has grown for 9 consecutive years.
- In FY2025, gross margin increased 1.2% year-over-year.
- Currently 8.0pp above the Health Care sector average.
- Lowest gross margin in the period was in FY2016.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 4.60 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 65.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 61.8% | +1.2% |
| FY2024 | 61.0% | +2.0% |
| FY2023 | 59.8% | +0.5% |
| FY2022 | 59.5% | +1.3% |
| FY2021 | 58.8% | +1.2% |
| FY2020 | 58.0% | +2.3% |
| FY2019 | 56.7% | +1.1% |
| FY2018 | 56.1% | +0.7% |
| FY2017 | 55.7% | +1.4% |
| FY2016 | 54.9% | -1.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026